Vitafusion is the first gummy brand to clinically prove bioequivalence with traditional vitamins and capsules, firm says

Photo © iStockphoto.com/nito100

Two unpublished clinical studies have tested the bioequivalence of vitamin C and vitamin D gummies from Vitafusion (Ewing, NJ) compared to traditional tablets. The vitamin D study, conducted by the Medical University of South Carolina, found that the Vitafusion vitamin D3 gummy performed better than tablets, having great bioavailability. The vitamin C study conducted by researchers from KGK Science saw no significant differences in absorption between the Vitafusion gummy and tablets. This makes Vitafusion gummies the first gummy company to have clinically proven bioequivalence to these traditional delivery forms, says the company.

“Gummy vitamins are relatively new to the nutrition scene,” said Laurie Kirschner, director of marketing for Vitafusion, in a press release. “As such, many people often wonder if gummies-because they taste so good-are as effective as traditional pill vitamins and may be hesitant to try them. It is now clinically proven that Vitafusion gummies are equal to their traditional counterparts. And, there is certainly no question that consumers love the taste and enjoyable experience of Vitafusion gummy vitamins. And now everyone can feel confident that essential nutrients in Vitafusion gummies are absorbed into your body-where you need it, when you need it.”

“Bioequivalence, in this case, simply means that two vitamins with identical active ingredients administered at the same dose but in different delivery forms possess similar bioavailability and produce the same effect,” said Annahita Ghassemi, director of global R&D, toxicology, and clinical affairs for Church & Dwight Company, Inc., Vitafusion’s parent firm. “Both studies were conducted under scientifically robust testing protocols with healthy, adult female and male subjects of similar age and body mass index (BMI).”

Photo is stock photo and not of Vitafusion gummies